Knüsli C, Ruff P, Laffer U, Stoll H R, Obrist R, Weber W, Obrecht J P
Department of Internal Medicine, University of Basel, Switzerland.
Acta Med Austriaca. 1989;16(3-4):70-3.
In a group of 31 patients a port-a-cath-system for intraperitoneal chemotherapy was installed. From 23 evaluable patients 9 showed a tumor remission, but only 1 was a patient with gastrointestinal carcinoma. All others were patients with ovarial carcinoma. The median survival rate of all patients was 9 months after implantation of the intraperitoneal catheter. 50% of all patients with gastrointestinal carcinoma died within the first 6 months, only 1 of 11 patients with ovarial carcinoma died in this period.
在一组31例患者中安装了用于腹腔内化疗的植入式静脉输液港系统。在23例可评估的患者中，9例出现肿瘤缓解，但只有1例是胃肠道癌患者。其他均为卵巢癌患者。腹腔内导管植入后，所有患者的中位生存期为9个月。所有胃肠道癌患者中有50%在最初6个月内死亡，在此期间11例卵巢癌患者中只有1例死亡。
